Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival.
Adjuvant and salvage radiotherapy for urothelial cell carcinoma of the upper urinary tract: experience in a single institution.
GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy.
Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma.
The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity.
Identification of a high-risk subgroup of patients with resected pT3 oral cavity cancer in need of postoperative adjuvant therapy.
PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.
PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity.
Tongue and buccal mucosa carcinoma: is there a difference in outcome?
Primary Tumor Site as a Predictor of Treatment Outcome for Definitive Radiotherapy of Advanced-Stage Oral Cavity Cancers.
Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy.
Treatment rults of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates.
Outcome Analysis of Patients with pN2 Oral Cavity Cancer.
Hypothyroidism After Radiotherapy for Nasopharyngeal Cancer Patients.
Prognostic significance of immunohistochemically detected lymph node micrometastases in pT0N0 esophageal squamous cell carcinoma.
Adjuvant androgen deprivation lost its benefit after premature termination: an experience of combined modality treatment on prostate cancer.
To customize radiotherapy record sheet with ARIA oncology information system.
Using Sybase InfoMaker To design and output clinical reports From ARIA Oncology Information System.
Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. .
Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up.
Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: The role of standardized uptake value.
Treatment outcome of combined modalities for buccal cancers: unilateral or bilateral neck radiation?
Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection.
High-Dose-Rate Brachytherapy Plus External Beam Radiotherapy for T1 to T3 Prostate Cancer: An Experience in Taiwan.
Combined Modality Treatment for Advanced Oral Tongue Squamous Cell Carcinoma.
Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma.
Preliminary Treatment Results of Intensity-Modulated Radiotherapy for Prostate Cancer.
Treatment results of tongue cancer in patient younger than 40 years old.
The effect of fixed couch-isocenter distance treatment on radiotherapy in rectal cancer patients.
